Cargando…

Impact of Chronic Inflammation, Assessed by hs-CRP, on the Association between Red Cell Distribution Width and Arterial Cardiovascular Disease: The Tromsø Study

Red cell distribution width (RDW), a measure of variability in size of circulating erythrocytes, is associated with arterial cardiovascular disease (CVD), but the underlying mechanism remains unclear. We aimed to investigate the impact of chronic inflammation as measured by high-sensitivity C-reacti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lappegård, Jostein, Ellingsen, Trygve S., Hindberg, Kristian, Mathiesen, Ellisiv B., Njølstad, Inger, Wilsgaard, Tom, Løchen, Maja-Lisa, Brækkan, Sigrid K., Hansen, John-Bjarne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Georg Thieme Verlag KG 2018
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524874/ https://www.ncbi.nlm.nih.gov/pubmed/31249941 http://dx.doi.org/10.1055/s-0038-1651523

Ejemplares similares

Red Cell Distribution Width and Risk of Atrial Fibrillation and Subsequent Thromboembolism: The Tromsø Study
por: Hald, Erin M., et al.
Publicado: (2020)

Red Cell Distribution Width Is Associated With Incident Myocardial Infarction in a General Population: The Tromsø Study
por: Skjelbakken, Tove, et al.
Publicado: (2014)

The association between red cell distribution width and venous thromboembolism is not explained by myocardial infarction, stroke, or cancer
por: Ellingsen, Trygve S., et al.
Publicado: (2018)

Atrial fibrillation, venous thromboembolism, ischemic stroke, and all‐cause mortality: The Tromsø study
por: Hald, Erin Mathiesen, et al.
Publicado: (2020)

Atherosclerotic Risk Factors and Risk of Myocardial Infarction and Venous Thromboembolism; Time-Fixed versus Time-Varying Analyses. The Tromsø Study
por: Småbrekke, Birgit, et al.
Publicado: (2016)

Venous Thromboembolism Increases the Risk of Atrial Fibrillation: The Tromsø Study
por: Hald, Erin M., et al.
Publicado: (2014)

Myocardial infarction, prothrombotic genotypes, and venous thrombosis risk: The Tromsø Study
por: Sejrup, Joakim K., et al.
Publicado: (2020)

Ischemic Stroke and Risk of Venous Thromboembolism in the General Population: The Tromsø Study
por: Rinde, Ludvig B., et al.
Publicado: (2016)

Joint effect of myocardial infarction and obesity on the risk of venous thromboembolism: The Tromsø Study
por: Sejrup, Joakim K., et al.
Publicado: (2022)

Association of occasional smoking with total mortality in the population-based Tromsø study, 2001–2015
por: Løchen, Maja-Lisa, et al.
Publicado: (2017)

Cohort profile: The Tromsø Study
por: Jacobsen, Bjarne K, et al.
Publicado: (2012)

Impact of Venous Thromboembolism on the Formation and Progression of Carotid Atherosclerosis: The Tromsø Study
por: Lind, Caroline, et al.
Publicado: (2017)

Data from national health registers as endpoints for the Tromsø Study: Correctness and completeness of stroke diagnoses
por: Varmdal, Torunn, et al.
Publicado: (2021)

Cardiovascular health and the modifiable burden of incident myocardial infarction: the Tromsø Study
por: Wilsgaard, Tom, et al.
Publicado: (2015)

Sex-Specific Associations between Blood Pressure and Risk of Atrial Fibrillation Subtypes in the Tromsø Study
por: Espnes, Hilde, et al.
Publicado: (2021)

Temporal Trends in Incidence and Case Fatality of Intracerebral Hemorrhage: The Tromsø Study 1995-2012
por: Carlsson, Maria, et al.
Publicado: (2016)

Associations Between Common and Rare Exonic Genetic Variants and Serum Levels of 20 Cardiovascular-Related Proteins: The Tromsø Study
por: Solomon, Terry, et al.
Publicado: (2016)

Serum osteoprotegerin and renal function in the general population: the Tromsø Study
por: Vik, Anders, et al.
Publicado: (2017)

Hypothetical interventions and risk of myocardial infarction in a general population: application of the parametric g-formula in a longitudinal cohort study—the Tromsø Study
por: Wilsgaard, Tom, et al.
Publicado: (2020)

The DBP Phenotype Gc-1f/Gc-1f Is Associated with Reduced Risk of Cancer. The Tromsø Study
por: Jorde, Rolf, et al.
Publicado: (2015)

Blood pressure target achievement and antihypertensive medication use in women and men after first-ever myocardial infarction: the Tromsø Study 1994–2016
por: Hopstock, Laila A, et al.
Publicado: (2018)

Validating Acute Myocardial Infarction Diagnoses in National Health Registers for Use as Endpoint in Research: The Tromsø Study
por: Varmdal, Torunn, et al.
Publicado: (2021)

Atrial Fibrillation and Cause‐Specific Risks of Pulmonary Embolism and Ischemic Stroke
por: Hald, Erin M., et al.
Publicado: (2018)

Genetic Variations in the Vitamin D Receptor Predict Type 2 Diabetes and Myocardial Infarction in a Community-Based Population: The Tromsø Study
por: Zostautiene, Ieva, et al.
Publicado: (2015)

Correction: Genetic Variations in the Vitamin D Receptor Predict Type 2 Diabetes and Myocardial Infarction in a Community-Based Population: The Tromsø Study
por: Martinaityte, Ieva, et al.
Publicado: (2016)

Longitudinal and secular trends in total cholesterol levels and impact of lipid-lowering drug use among Norwegian women and men born in 1905–1977 in the population-based Tromsø Study 1979–2016
por: Hopstock, Laila Arnesdatter, et al.
Publicado: (2017)

Fish consumption, fish oil supplements and risk of atherosclerosis in the Tromsø study
por: Johnsen, Stein Harald, et al.
Publicado: (2018)

Association between diastolic dysfunction and future atrial fibrillation in the Tromsø Study from 1994 to 2010
por: Tiwari, Sweta, et al.
Publicado: (2015)

Sex Differences in the Impact of Body Mass Index on the Risk of Future Atrial Fibrillation: Insights From the Longitudinal Population‐Based Tromsø Study
por: Ball, Jocasta, et al.
Publicado: (2018)

CHA(2)DS(2)-VASc score, left atrial size and atrial fibrillation as stroke risk factors in the Tromsø Study
por: Tiwari, Sweta, et al.
Publicado: (2016)

Polymorphisms Related to the Serum 25-Hydroxyvitamin D Level and Risk of Myocardial Infarction, Diabetes, Cancer and Mortality. The Tromsø Study
por: Jorde, Rolf, et al.
Publicado: (2012)

Achievements of primary prevention targets in individuals with high risk of cardiovascular disease: an 8-year follow-up of the Tromsø study
por: Hagen, Amalie Nilsen, et al.
Publicado: (2022)

Low Pain Tolerance Is Associated With Coronary Angiography, Coronary Artery Disease, and Mortality: The Tromsø Study
por: Fladseth, Kristina, et al.
Publicado: (2021)

Long-term blood pressure trajectories and incident atrial fibrillation in women and men: the Tromsø Study
por: Sharashova, Ekaterina, et al.
Publicado: (2020)

Change in cardiovascular risk assessment tool and updated Norwegian guidelines for cardiovascular disease in primary prevention increase the population proportion at risk: the Tromsø Study 2015–2016
por: Nilsen, Amalie, et al.
Publicado: (2021)

Data on gender contrasts in the risk of incident myocardial infarction by age. The Tromsø Study 1979–2012
por: Albrektsen, Grethe, et al.
Publicado: (2017)

Prevalence of general and abdominal obesity in 2015–2016 and 8-year longitudinal weight and waist circumference changes in adults and elderly: the Tromsø Study
por: Løvsletten, Ola, et al.
Publicado: (2020)

Uric acid predicts mortality and ischaemic stroke in subjects with diastolic dysfunction: the Tromsø Study 1994–2013
por: Norvik, Jon V., et al.
Publicado: (2017)

Weight Change and Risk of Venous Thromboembolism: The Tromsø Study
por: Horvei, Lars Daae, et al.
Publicado: (2016)

Lifestyle factors as mediators of area-level socio-economic differentials in cardiovascular disease risk factors. The Tromsø Study
por: Tiwari, Sweta, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_754950evcl3cjp3f039ki4g2o3